Hypocalcemia is most commonly seen within the first six months of GLP-1 receptor agonist therapy, while hypercalcemia is noted to occur after at least six months of therapy
Metal-based systems (MnO, Cu 2 , Fe 3 ) deplete GSH and generate ROS, with imaging potential, though metal toxicity and accumulation are concerns
While diet alone will not shrink uterine fibroids, it can help manage symptoms and complications
SGD can reduce the high serum testosterone levels in women with oligomenorrhea or amenorrhea, and some of these infertile women are able to conceive (Takeuchi, 1988)
Alcohol, inflammation, and microbiota in alcoholic liver disease